Magazine: UK’s new Netflix-style funding model for antibiotics goes live
After trialling a subscription-style system for procuring antimicrobial drugs, the UK’s National Health Service recently announced that it will formalise…
After trialling a subscription-style system for procuring antimicrobial drugs, the UK’s National Health Service recently announced that it will formalise…
The ongoing European Union (EU) elections, a revision of key legislation governing the pharmaceutical and biotech industry in Europe, and…
Tackling two of the buzziest trends in pharma right now; AI and mRNA therapeutics, is high on the agenda of…
An upcoming session designed to gather suggestions to optimise the US Food and Drug Administration (FDA) Advisory Committee (AdCom) meetings…
The last year was a momentous one for RSV research with more than one vaccine and a new treatment for…
As the number of specialised gene therapies continues to grow in the biotech sector, one particular subtype— those using adeno-associated…
In the last few years, multimillion dollar revenues driven by popular demand, and even higher projections for the future have…
Running a successful clinical trial requires a combination of sector expertise, an eye towards emerging technologies and efforts to consider…
In this year’s first issue, we take the opportunity to look back at major drug approvals and regulatory news to…
It is not easy to pick a name for a drug. Not only are there chemical and non-proprietary names to…